KLF2 and neoplasm: A recent study illustrated that the microRNA302-367-ERK1/2-KLF2-S1PR1 pathway can restrict angiogenesis and stabilize vascular cells, which means that the ERK1/2-KLF2-S1PR1 pathway may promote tumor growth by stimulating angiogenesis [81].